Parameter | Baseline visit | Follow-up visit |
---|---|---|
Inclusion/exclusion criteria | × | |
Informed consent, medical records release, and contact order form | × | |
Demographicsa | × | |
Other study participation | × | × |
Hypoparathyroidism etiology (primary cause)b | × | |
Family history | × | |
Medical history/condition summary | × | |
Height and weight | × | × |
Pregnancy | × | × |
Clinical laboratory evaluations | × | × |
Other medical proceduresc | × | × |
Management of chronic hypoparathyroidism | × | × |
rhPTH(1-84) dosing informationd | × | × |
Historical PTH dosing informatione | × | |
Prior and concomitant medications, including over-the-counter medications | × | × |
Outcome evaluations (socioeconomic status and social history) | × | |
Outcome evaluations (Hypoparathyroidism Symptom Diary, WPAI:SHP, SF-36, SF-10) | ×f | × |
Other questionnaires (signs and symptoms, hospitalization annual form) | × | × |
Vital status database searches | ×g | |
Adverse events | ×f,h | × |
Patient discontinuation | × |